Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Black, Hispanic individuals up to 30% less likely to receive post-stroke treatment
Black and Hispanic patients were less likely to be treated for stroke complications than their white counterparts, particularly treatment of arousal, spasticity and mood, per data presented at the International Stroke Conference.
Gluconic acid level may predict hypertension, stroke in Black adults
Elevated gluconic acid, a plasma metabolite, could be a potential race-specific indicator of hypertension and ischemic stroke among Black adults, according to a study presented at the International Stroke Conference.
Log in or Sign up for Free to view tailored content for your specialty!
Residents of ‘food swamps’ could be at increased risk for stroke
Residents of “food swamp” communities, which have a higher prevalence of fast-food options than healthy options, may be at increased risk for incident stroke, according to research presented at the International Stroke Conference.
Risk for recurrent stroke declines over past 20 years, particularly in women survivors
Recurrent stroke risk has declined over the past 2 decades, with women experiencing a twofold decline compared with men, according to preliminary research presented at the International Stroke Conference.
Disparities in adversity linked to differences in brain structure of Black, white children
Black children on average undergo more family conflict, material hardship and traumatic events than white children, resulting in differences in gray matter volume in key brain regions and disorders such as PTSD, data show.
Long-term insertable cardiac monitoring after ischemic stroke improves AF detection
Long-term insertable cardiac monitoring for atrial fibrillation among patients with ischemic stroke of atherosclerotic origin improved AF detection 10-fold compared with standard of care, a speaker reported.
Incidence of infective endocarditis-related stroke linked to rise in IV drug use
Infective endocarditis-related stroke was increasingly associated with IV drug use and fewer traditional risk factors such as diabetes and hypertension, a trend researchers attributed to recent demographics of the opioid epidemic.
Oligomerix launches phase 1a trial for tau self-association inhibitor for Alzheimer’s
Dosing has begun in participants enrolled in a phase 1a clinical trial of OLX-07010, an oral small molecule inhibitor of tau self-association for Alzheimer’s disease, manufacturer Oligomerix announced in a press release.
Athira announces clinical trials for Alzheimer’s, Parkinson’s, ALS treatments in 2023
Athira Pharma Inc. revealed its list of planned clinical trials for 2023, which include development of therapeutics for Alzheimer’s disease, Parkinson’s disease and ALS.
Study reveals hundreds of excess deaths among US physicians during COVID-19 pandemic
In the United States, there were more than 600 excess deaths among physicians from March 2020 to December 2021, according to a research letter published in JAMA Internal Medicine.
-
Headline News
Q&A: 1 in 5 COVID-19 deaths due to strain of hospital overcrowding
September 25, 20244 min read -
Headline News
Impact of Dobbs ‘immediate and profound’ on OB/GYN residents in Wisconsin
September 25, 20246 min read -
Headline News
FDA approves second Niemann-Pick disease type C treatment
September 25, 20241 min read
-
Headline News
Q&A: 1 in 5 COVID-19 deaths due to strain of hospital overcrowding
September 25, 20244 min read -
Headline News
Impact of Dobbs ‘immediate and profound’ on OB/GYN residents in Wisconsin
September 25, 20246 min read -
Headline News
FDA approves second Niemann-Pick disease type C treatment
September 25, 20241 min read